Cargando…
Risk Management in Drug-Device Combination Product Development
Breakthrough innovations in drug and biologic based therapies as well as technological developments in design and development of medical devices have led to the rapid rise in the use of combination products in the last few decades. The resulting maturity of combination products as a global market ca...
Autores principales: | Kumoluyi, Robin, Khanolkar, Amit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356918/ https://www.ncbi.nlm.nih.gov/pubmed/35753035 http://dx.doi.org/10.1007/s43441-022-00425-w |
Ejemplares similares
-
Cardiovascular Risk Assessment and Management in Developing Countries
por: Mendis, Shanthi
Publicado: (2005) -
In Silico Methods for Development of Generic Drug–Device Combination Orally Inhaled Drug Products
por: Walenga, Ross L., et al.
Publicado: (2019) -
Supraglottic airway devices in airway management of obese patients
por: Singh, Manpreet
Publicado: (2019) -
Consensus about managing gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs?
por: Yeomans, Neville D
Publicado: (2015) -
Assessing the Benefit-Risk for New Drugs: Are the FDA's Endocrinologic and Metabolic Drugs Advisory Committee and the Division of Metabolism and Endocrinology Products in sync?
por: Brass, Eric P.
Publicado: (2013)